People: EXACT Sciences Corporation (EXAS.O)

EXAS.O on Consolidated Issue listed on NASDAQ Capital Market

3.80USD
9 Feb 2010
Price Change (% chg)

$-0.16 (-4.04%)
Prev Close
$3.80
Open
--
Day's High
$3.97
Day's Low
$3.79
Volume
55,631
Avg. Vol
91,709
52-wk High
$4.50
52-wk Low
$0.76

view people for:

Summary

Name Age Since Current Position
Zenner, Patrick 62 2008 Chairman of the Board
Conroy, Kevin 43 2009 President,Chief Executive Officer,Director
Arora, Maneesh 40 2009 Chief Financial Officer, Senior Vice President
Lidgard, Graham 60 2009 Chief Scientific Officer
Crawford, Sally 56 2008 Director
Kania, Edwin 51 1995 Director
Willsey, Lance 47 2000 Director
Mack, Connie 68 2001 Director
Connelly, James 62 2009 Director
Napier, Katherine 54 2009 Director
» Insider Trading

Biographies

Name Description
Zenner, Patrick Patrick J. Zenner has served as Chairman and Director of Exact Sciences Corporation. He has served as a director of the Company since March 2003 and as chairman of the board since April 2008. From July 2007 until March 2008, Mr. Zenner served as Company's interim Chief Executive Officer. In January 2001, Mr. Zenner retired from Hoffmann-La Roche Inc., North America, the prescription drug unit of the Roche Group, a leading research-based health care enterprise, where he served as President and Chief Executive Officer since 1993. Mr. Zenner joined Hoffman-La Roche Inc. in 1969 and held a number of domestic and international management positions at the company prior to becoming Chief Executive Officer in 1993. Mr. Zenner also serves as a director of ArQule, Inc., Curagen Corporation, Geron Corporation, West Pharmaceutical Services, Inc. and Xoma Ltd. Mr. Zenner also served as interim Chief Executive Officer of Curagen Corporation from May 2005 to March 2006. Mr. Zenner holds a BS in business administration from Creighton University and an MBA from Fairleigh Dickinson University and is a Trustee of both universities.
Conroy, Kevin Kevin T. Conroy is President,Chief Executive Officer,Director of Exact Sciences Corporation. He has served as President and Chief Executive Officer since April 2, 2009. Mr. Conroy served as president and chief executive of Third Wave Technologies, Inc. from December 2005 until the acquisition of Third Wave Technologies, Inc. by Hologic, Inc. in July 2008. He joined Third Wave Technologies, Inc. in July 2004 and served as general counsel until December 2005. Prior to joining Third Wave Technologies, Inc., Mr. Conroy served as intellectual property counsel at GE Healthcare. Before joining GE Healthcare, Mr. Conroy was chief operating officer of two early-stage, venture-backed technology companies in Northern California. Prior to those positions, he was an intellectual property litigator at two Chicago law firms, McDermott Will & Emery, and Pattishall, McAuliffe, Newbury, Hilliard and Geraldson, where he was a partner. He earned a bachelor's of science degree in electrical engineering at Michigan State University and a J.D. from the University of Michigan.
Arora, Maneesh Maneesh Arora has served as Senior Vice President and Chief Financial Officer of Exact Sciences Corporation since April 2, 2009. Mr. Arora served as chief financial officer of Third Wave Technologies, Inc. from January 2006 until the acquisition of Third Wave Technologies, Inc. by Hologic, Inc. in July 2008. He joined Third Wave Technologies, Inc. in January 2003 as director of strategy and was promoted successively to vice president and senior vice president in 2004. Prior to joining Third Wave Technologies. Inc., Mr. Arora was director of corporate strategy for Nalco Chemical Company. He began his career at Kraft Foods as a financial analyst and held several positions of increasing responsibility during his nine years there. He earned a bachelor's degree in economics from the University of Chicago and a master of business administration degree from the Kellogg Graduate School of Management.
Lidgard, Graham Dr. Graham P. Lidgard, Ph.D., is Chief Scientific Officer of Exact Sciences Corp. Dr. Lidgard led the research and development organization at Gen-Probe Inc. that developed that company's Procleix blood-screening products and Aptima sexually-transmitted disease products. These product lines generated more than $400 million in revenues during 2008. Dr. Lidgard also created and led the system development group at Gen-Probe that developed its fully-automated Tigris system. Prior to joining Gen-Probe, Dr. Lidgard was co-founder and vice president of product development of Matritech Inc., a Cambridge, Mass.-based developer of diagnostic products for the early detection of bladder cancer. The company was acquired by Inverness Medical Innovations Inc. in 2007. Before he co-founded Matritech, Dr. Lidgard held senior positions at Ciba Corning Diagnostics Corp.'s worldwide diagnostics group. While at Ciba Corning, he was involved in the development of more than 70 510(k)-cleared products. He led the program for the development of the magnetic particle chemiluminescent technology that became the ACS:180 and Centaur systems. He also directed the company's business development and marketing groups, and held operations and global product management positions. Dr. Lidgard joins Exact Sciences from Nanogen Inc., where he was senior vice president of research and development. While at Nanogen, he managed its point of care and molecular diagnostics research and development groups. Dr. Lidgard earned a bachelor's degree with honors and a doctorate in biological chemistry from the University of Manchester in England.
Crawford, Sally Sally W. Crawford has served as a director of Exact Sciences Corporation since August 1999 and as Chairperson of the Company from January 2006 to April 2008. Ms. Crawford has been an independent healthcare consultant since January 1997. From April 1985 to January 1997, Ms. Crawford served as Chief Operating Officer for Healthsource, Inc., a publicly-traded managed care organization which she co-founded. As Chief Operating Officer of Healthsource, Ms. Crawford was responsible for reviewing and establishing systems for financial reporting. Ms. Crawford also served as the Chief Executive Officer of several subsidiaries of Healthsource, and was responsible for the analysis and oversight of the subsidiaries' financial reporting. Ms. Crawford is also a director of CombinatoRx, Incorporated, Hologic, Inc., Universal American Corp. and Insulet Corporation. Ms. Crawford holds a BA in English from Smith College and an MS in communications from Boston University.
Kania, Edwin Edwin M. Kania, Jr., has served as a director of Exact Sciences Corporation since September 1995. Since 1999, Mr. Kania has been Managing Partner and Chairman of Flagship Ventures, a Boston-based venture capital firm that he co-founded and that also manages funds raised by OneLiberty Ventures. Prior to co-founding Flagship Ventures, Mr. Kania was a General Partner at OneLiberty Ventures. Mr. Kania is also a director of Aspect Medical Systems, Inc. Mr. Kania holds a degree in physics from Dartmouth College and an MBA from Harvard Business School.
Willsey, Lance Lance Willsey, MD has served as a director of Exact Sciences Corporation since May 2000. Dr. Willsey was a founding partner of DCF Capital from July 1998 to April 2002. From July 1997 to July 1998, Dr. Willsey served on the Staff Department of Urologic Oncology at Dana Farber Cancer Institute at Harvard University School of Medicine. From July 1996 to July 1997, Dr. Willsey served on the Staff Department of Urology at Massachusetts General Hospital at Harvard University School of Medicine, where he was also a urology resident from July 1992 to July 1996. Dr. Willsey is also a director of Exelixis, Inc. Dr. Willsey holds a BS in physiology from Michigan State University and an MS in biology and an MD from Wayne State University.
Mack, Connie Connie Mack, III has served as a director of Exact Sciences Corporation since June 2001. Since January 2007, Mr. Mack has been a partner and senior policy advisor of Liberty Partners of Florida, LLC, and since February 2005, Mr. Mack has served as senior policy advisor at King & Spalding LLP. From February 2001 to February 2005, Mr. Mack served as a senior policy advisor at Shaw Pittman LLP. Mr. Mack was first elected to public office as a U.S. Congressman for the 13th district in the State of Florida in 1982. In 1988, he was elected to a six-year term in the U.S. Senate from the State of Florida and was re-elected for a second term in 1994. He did not seek re-election in 2000. Mr. Mack was the Republican Conference Secretary from 1995 to 1997. He was Chairman of the Senate Republican Conference from 1997 to 2001 and Chairman of the Joint Economic Committee from 1999 to 2001. Mr. Mack is also a director of Darden Restaurants Inc., Genzyme Corporation, Moody's Corporation and Mutual of America Life Insurance Company. Mr. Mack holds a BS in Business Administration from the University of Florida.
Connelly, James James Connelly has served as Director of Exact Sciences Corporation. He is a partner in the Foley & Lardner law firm, where he has served as founding chairman of the Health Law Practice. He brings to the EXACT Sciences board of directors more than 25 years of experience providing strategic business and legal advice to large health care networks, clinics and laboratories. He also has advised a number of emerging biotechnology and life sciences companies. He was a director of Third Wave Technologies Inc. from 2005 until its acquisition by Hologic Inc. in 2008. Mr. Connelly earned his bachelor's degree from Marquette University and his law degree from the Georgetown University Law Center, where he was editor-in-chief of the Georgetown Law Review.
Napier, Katherine Katherine Napier has served as Director of Exact Sciences Corporation. He is a 20-year veteran of Procter & Gamble, where from 1979 to 2002, she rose from assistant brand manager to vice president and general manager of the company's North American pharmaceutical business. That business experienced unprecedented growth during her five-year tenure, which included the launch of the osteoporosis drug Actonel. Actonel grew to $1 billion in revenue more quickly than any of the company's brands. Ms. Napier also served as senior vice president of marketing at McDonald's Corporation, where she led the company's reinvigoration of its business with women and families. She received her bachelor's degree in economics and studio fine arts from Georgetown University, and earned a master of business administration degree in marketing and finance from Xavier University. Ms. Napier serves on the board of directors of the Alberto Culver Co., Catholic Health Care Partners, Xavier University, and the board of visitors of Wake Forest University Calloway School of Business. She was a director of Mentor Corp. before its acquisition earlier this year by Johnson & Johnson and of Third Wave Technologies Inc. until its acquisition by Hologic Inc. in 2008.

Basic Compensation

Name Fiscal Year Total
Zenner, Patrick 32,267
Conroy, Kevin --
Arora, Maneesh --
Lidgard, Graham --
Crawford, Sally --
Kania, Edwin --
Willsey, Lance --
Mack, Connie --
Connelly, James --
Napier, Katherine --
As Of 30 Dec 2008

Insider Trading

Name Shares Traded Price
LIDGARD GRAHAM PETER 2,665 $4.17
CONROY KEVIN T 15,288 $0.00
ARORA MANEESH 3,178 $4.17
LIDGARD GRAHAM PETER 6,595 $0.00
BERGER BARRY M 2,905 $4.17
BERGER BARRY M 8,273 $0.00
ARORA MANEESH 8,633 $0.00
CONROY KEVIN T 5,229 $4.17
CONROY KEVIN T 9,000 $2.22
KANIA EDWIN M JR 5,339 $0.00
MCGILLICUDDY CORNELIUS III 5,339 $0.00
CONNELLY JAMES P 5,339 $0.00
NAPIER KATHERINE S 5,339 $0.00
WILLSEY LANCE 5,339 $0.00
ZENNER PATRICK J 5,339 $0.00
CRAWFORD SALLY W 5,339 $0.00
NAPIER KATHERINE S 17,482 $0.00
CONNELLY JAMES P 17,482 $0.00
MCGILLICUDDY CORNELIUS III 60,344 $0.00
CRAWFORD SALLY W 60,344 $0.00
ZENNER PATRICK J 64,655 $0.00
WILLSEY LANCE 43,103 $0.00
KANIA EDWIN M JR 60,344 $0.00
SINGER MICHAEL E 130,000 $0.00
KANIA EDWIN M JR 10,000 $0.71
» Full list on Insider Trading
view people for: